Opsona Therapeutics

Opsona Therapeutics (Dublin, Ireland) is a leading clinical stage biopharmaceutical company focused on the treatment of autoimmune/inflammatory diseases and cancers. The drug discovery and development is focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signaling in human immunology and the lead molecule OPN-305 is currently in a phase II clinical trials for the prevention of Delayed Graft Function in renal transplantation – an area of high unmet medical need.

Peter Benson, MSc

Managing Partner

Mobile: +45 40 80 48 69
Email Click here to contact